|

Chimeric Natural Killer Receptor Universal T-cells (CNK-UT) Clinical Trials

1 actively recruiting trial

Pipeline

Phase 1: 1

Top Sponsors

  • Nanjing Children's Hospital1

Indications

  • Neuroblastoma, Recurrent, Refractory1
  • Cancer1

Other1 trial

Chimeric Natural Killer Receptor-Universal T Cells for Relapsed or Refractory Neuroblastoma
Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.